Skip to main content
. 2008 Nov 4;99(11):1775–1785. doi: 10.1038/sj.bjc.6604769

Table 3. Multivariate analysis (N=260).

  OS
DFS
  HR 95% CI P-value HR 95% CI P-value
EGFR
 <75th percentile 1 1
 ⩾75th percentile 1.71 1.00–2.93 0.050 1.52 0.95–2.44 0.079
             
HER2
 <Median 1      
 ⩾Median 1.84 1.07–3.17 0.027      
             
HER3
 <Median 1      
 ⩾Median 0.53 0.30–0.91 0.021      
             
HER4
 <Median       1
 ⩾Median       0.58 0.36–0.93 0.022
             
Number of nodes
 0–3 1 1
 ⩾4 2.42 1.08–5.34 0.032 2.70 1.38–5.28 0.004
             
Grade
 I–II       1
 III-Undifferentiated       1.52 0.96–2.41 0.071
             
Adjuvant hormonotherapy
 No 1 1
 Yes 0.48 0.23–0.99 0.50 0.52 0.27–0.99 0.046
             
Group of randomisation
 E-T-CMF 1 1
 E-CMF 0.85 0.51–1.41 0.526 0.93 0.60–1.45 0.928